Loncar Investments

  • Loncar Cancer Immunotherapy ETF

Loncar Cancer Immunotherapy ETF

Quarterly Returns



Years Q1 Q2 Q3 Q4 Annual
2015 0% 0% 0% 14.3% 2.4%
2016 -24% 4.7% 13.6% -17.7% -25.6%
2017 14.4% -5.2% 17.5% -13% 13.6%
2018 22.2% -13% 2.3% -23.6% -20.6%
2019 11.4% -0.4% -13% 26.2% 24.2%
2020 -16.7% 38.7% 171.1% -41.5% 83.3%
2021 17% 4.3% -0.7% 8.2% -44.6%
2022 -24.4% -15.6% -3.6% -6.3% -42.3%
2023 -12.7% 7.8% -15.2% 28% -1.9%
2024 23.4% -5% 0% 0% 8%
Data SourcesDisclaimer